about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorOpioid antagonists for smoking cessationOpioid antagonists for alcohol dependenceOpioid antagonists for smoking cessationOpioid antagonists for alcohol dependenceEvidence-based practices for substance use disordersChronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapseEvidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intakePharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependenceThe orexin system regulates alcohol-seeking in ratsPharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsyAdvances in Medications and Tailoring Treatment for Alcohol Use DisorderSystematic review and meta-analysis of opioid antagonists for smoking cessationPrevention of sudden unexpected death in epilepsy: a realistic goal?Rational development of addiction pharmacotherapies: successes, failures, and prospectsThe Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.A model of alcohol drinking under an intermittent access schedule using group-housed miceReward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviorsNalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J miceEvidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in miceInfluence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholismThe phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded ratsThe dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administrationEffects of rearing conditions on behaviour and endogenous opioids in rats with alcohol access during adolescenceEffects of acute ethanol on corticotropin-releasing hormone and β-endorphin systems at the level of the rat central amygdalaWhy alcoholism is a disease.The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disordersUpdate on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Naltrexone long-acting formulation in the treatment of alcohol dependence.Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis.Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.Opioid antagonists for alcohol dependence.Pretreatment with hydromorphone, a mu-opioid agonist, does not alter the acute behavioral and physiological effects of ethanol in humans.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.
P2860
Q22241964-00B96E62-FE26-402A-8D7C-357D8D80EC3EQ24202118-655A75EF-AB8C-4AA8-9F5D-5611A2175694Q24235797-1E0E7F50-EE22-4CEF-B9BE-594CB9D39CF6Q24243850-3BC5F795-C1FC-4E4D-BE31-750306F427A8Q24244900-3EB70D61-B1BA-410C-8A35-D64E3F93E4CAQ24614016-2F375CF3-7E78-414D-8431-002F064E91D3Q24633835-CB020680-46D8-4D98-A32E-0F3E468BEC26Q24651508-FF8723CF-48CF-4584-83B0-C5D3AE4BDF56Q24658266-72540448-2ED9-4904-9B59-A238B3150769Q24671740-1E67E12F-7E48-44B6-A5B9-457F66591BE3Q24793186-C91FA14B-2538-4EAB-8E0A-7908B740CCB5Q24810652-01E6EE0D-0B7A-4371-98E4-40ADF36E068DQ26770025-A72018D5-B4D3-474A-9436-B79F3BF1B26AQ26799814-0779D4C5-3698-4F40-8DDE-3F04C4C470DCQ26853570-BB61BBFD-B7B5-4986-93C9-568BCED1AF2AQ26998873-B59B0E6C-1FD1-4517-96E9-F940D3E4B5A7Q27025533-EDCCA5F2-1646-4EF4-BFA5-23B2A8046DA3Q27310644-935EBAD7-8196-44C8-9D8D-2697745BA4C7Q27333982-3868DF00-FFDB-4A75-9089-6681DB0A7023Q28209521-C333470B-E6FD-48DB-89AB-62EC4C7EC3DCQ28259148-3D673E7C-06D8-469B-8979-4BFE7D3D9E9DQ28286555-D0D12A06-AB0B-4A9E-B529-E74623160F00Q28296440-ACE85FF1-64D3-45C9-B887-C453A0B1F416Q28361170-772520F7-789F-423B-81DD-F7B7A2DE3009Q28388227-083BA7DA-29E0-4081-883D-3ECA3CE8CFA3Q28483933-30458486-7F6F-4F85-B998-264103D267C5Q28533990-71EDDEED-5958-44BC-9D8C-60783D5AC36CQ28572318-0B19A275-B45C-4C17-89CE-0BFF59768D79Q30420449-AF16BC59-21F8-474B-B465-54DFED5B9FF4Q30423211-045DC3DB-819A-400C-8220-5B5597BE3246Q30440516-952668AD-88A0-4870-8468-67FED4C29089Q30441807-F79F788E-1211-4B32-91AA-CCBD4638BAC6Q30479081-96E4FB58-19AD-4FE6-93E9-4C4A1A98E624Q30502320-A51DFCAA-59F5-4A95-AA47-A75B76C39306Q31083745-5777D8BD-2625-462F-A5C8-4F35DAED8E41Q31993903-7DF766D1-0ABC-4DE7-82AF-338939348103Q33319816-A7889804-CD7D-439F-B920-70D86BCFFAAFQ33330500-59F4D249-C75E-4BDC-A831-A18B988AA545Q33395349-2E693970-4920-434B-AD75-E46252FC069CQ33455500-688D4F9A-7986-4F3E-99C9-18C7D6BF0F8A
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Naltrexone in the treatment of alcohol dependence.
@ast
Naltrexone in the treatment of alcohol dependence.
@en
Naltrexone in the treatment of alcohol dependence.
@nl
type
label
Naltrexone in the treatment of alcohol dependence.
@ast
Naltrexone in the treatment of alcohol dependence.
@en
Naltrexone in the treatment of alcohol dependence.
@nl
prefLabel
Naltrexone in the treatment of alcohol dependence.
@ast
Naltrexone in the treatment of alcohol dependence.
@en
Naltrexone in the treatment of alcohol dependence.
@nl
P2093
P1433
P1476
Naltrexone in the treatment of alcohol dependence.
@en
P2093
Alterman AI
Hayashida M
O'Brien CP
Volpicelli JR
P304
P356
10.1001/ARCHPSYC.1992.01820110040006
P407
P577
1992-11-01T00:00:00Z